Significance of Oct-4 Transcription Factor as a Pivotal Therapeutic Target for CD44⁺/24⁻ Mammary Tumor Initiating Cells: Aiming at the Root of the Recurrence

Researchers attempted to identify previously unrecognized CSC survival factors that could be used as druggable targets for breast CSCs apoptosis regulators isolated from the triple-negative breast cancer line.